1. Home
  2. MLAB vs RZLT Comparison

MLAB vs RZLT Comparison

Compare MLAB & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$96.80

Market Cap

533.0M

Sector

Industrials

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.94

Market Cap

470.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
RZLT
Founded
1982
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.0M
470.9M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
MLAB
RZLT
Price
$96.80
$4.94
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$94.00
$9.67
AVG Volume (30 Days)
207.3K
2.3M
Earning Date
05-27-2026
05-13-2026
Dividend Yield
0.67%
N/A
EPS Growth
436.11
26.32
EPS
1.21
N/A
Revenue
N/A
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$5.41
N/A
P/E Ratio
$84.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$1.07
52 Week High
$113.99
$11.46

Technical Indicators

Market Signals
Indicator
MLAB
RZLT
Relative Strength Index (RSI) 44.55 62.77
Support Level $94.01 $2.91
Resistance Level $97.56 $9.80
Average True Range (ATR) 5.62 0.34
MACD 0.19 -0.03
Stochastic Oscillator 46.24 62.91

Price Performance

Historical Comparison
MLAB
RZLT

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: